Overview

  • Product nameAnti-FLAP antibody
    See all FLAP primary antibodies
  • Description
    Goat polyclonal to FLAP
  • Tested applicationsSuitable for: WB, ELISA, IHC-Pmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Rabbit, Horse, Dog, Cynomolgus Monkey, Macaque Monkey
  • Immunogen

    Synthetic peptide:

    HKVEHESRTQNGR

    by a Cysteine residue linker, corresponding to internal sequence amino acids 28-40 of Human FLAP.

  • Positive control
    • Human small intestine, lung and spleen tissues; U937 cell lysate.

Properties

Applications

Our Abpromise guarantee covers the use of ab113614 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB Use a concentration of 0.1 - 0.3 µg/ml. Predicted molecular weight: 18 kDa.
ELISA 1/128000.
IHC-P Use a concentration of 3.75 µg/ml.

Target

  • FunctionRequired for leukotriene biosynthesis by ALOX5 (5-lipoxygenase). Anchors ALOX5 to the membrane. Binds arachidonic acid, and could play an essential role in the transfer of arachidonic acid to ALOX5. Binds to MK-886, a compound that blocks the biosynthesis of leukotrienes.
  • Involvement in diseaseGenetic variations in ALOX5AP may be a cause of susceptibility to ischemic stroke (ISCHSTR) [MIM:601367]; also known as cerebrovascular accident or cerebral infarction. A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors.
    Note=Genetic variations in ALOX5AP may be associated with susceptibility to myocardial infarction. Involvement in myocardial infarction is however unclear: according to some authors (PubMed:14770184), a 4-SNP haplotype in ALOX5AP confers risk of myocardial infarction, while according to other (PubMed:17304054) ALOX5AP is not implicated in this condition.
  • Sequence similaritiesBelongs to the MAPEG family.
  • DomainThe C-terminal part after residue 140 is mostly unstructured.
  • Cellular localizationNucleus membrane. Endoplasmic reticulum membrane.
  • Information by UniProt
  • Database links
  • Alternative names
    • 5-lipoxygenase activating protein antibody
    • AL5AP_HUMAN antibody
    • ALOX 5AP antibody
    • ALOX5 AP antibody
    • ALOX5AP antibody
    • Arachidonate 5 lipoxygenase activating protein antibody
    • Arachidonate 5-lipoxygenase-activating protein antibody
    • Five lipoxygenase activating protein antibody
    • FLAP antibody
    • MK 886 binding protein antibody
    • MK-886-binding protein antibody
    see all

Anti-FLAP antibody images

  • Anti-FLAP antibody (ab113614) at 0.1 µg/ml + U937 cell lysate at 35 µg
    Developed using the ECL technique

    Predicted band size : 18 kDa
  • ab113614 at 3.75ug/ml staining FLAP in Formalin-fixed, Paraffin-embedded Human small intestine tissue by immunohistochemistry.
  • ab113614 at 3.75ug/ml staining FLAP in Formalin-fixed, Paraffin-embedded Human Lung tissue by immunohistochemistry.
  • ab113614 at 3.75ug/ml staining FLAP in Formalin-fixed, Paraffin-embedded Human spleen tissue by immunohistochemistry.

References for Anti-FLAP antibody (ab113614)

ab113614 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab113614.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"